Clinical activities focus on the diagnosis and treatment of acute and chronic diseases involving end-stage liver failure. The Hepatology Unit coordinates treatment programs with specialists, such as surgeons with expertise in transplantation and hepatobiliary surgery, interventional radiologists, endoscopists, pathologists, infectious disease specialists, and intensive care physicians.
Both inpatient and outpatient clinical activities focus on the following areas:
- Selection, assessment, and inclusion on the waiting list of liver transplant candidates
- Follow-up of liver transplant recipients
- Selection and assessment of patients requiring highly-specialized interventional radiology and endoscopy procedures (e.g., TIPS, intra-arterial treatments)
The Unit participates in national and international clinical studies, and is recognized as a point of reference for advanced treatments of such diseases as viral hepatitis, hepatitis A and B, hemochromatosis, non-alcoholic steatohepatitis, primary biliary cirrhosis, sclerosing cholangitis, Wilson’s disease, alpha-1-antitrypsin deficiency, hepatocellular carcinoma, cholangiocarcinoma, and other liver diseases.
Main scientific research areas:
- Treatment of post-transplant hepatitis C virus infections
- Prognostic models for selection of transplant patients
- Diagnosis and treatment of hepatocarcinoma
- Regenerative medicine and cell transplantation